(Total Views: 335)
Posted On: 06/29/2017 6:46:36 AM
Post# of 246

Summary audited financial statements for 2015 and 2014 are attached. From 2014 to 2015, sales
increased 28%; operating income rose 38%; net income was up 40%; and cash and cash equivalents
increased $682,637. In 2015, we sold our product and related services in 46 states and seven foreign
countries—the latter related mainly to research. And, we are seeing similar sales growth in 2016. https://pharmchek.com/investor-relations
Go PCHM
increased 28%; operating income rose 38%; net income was up 40%; and cash and cash equivalents
increased $682,637. In 2015, we sold our product and related services in 46 states and seven foreign
countries—the latter related mainly to research. And, we are seeing similar sales growth in 2016. https://pharmchek.com/investor-relations
Go PCHM

